SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (42157)5/12/2011 3:38:43 PM
From: E_K_S  Read Replies (1) of 78669
 
Hi Paul -

My Drugs watch list has been moving higher the last 14 days w/ all hitting 52wk highs. In particular, LLY my long term "Value" play w/ buys in 8/2009 & 4/2010 is finally moving close to $40.00/share. MRK is another big mover for me w/ buys in 10/08, 11/08. & 6/09 may be a $40 candidate soon too.

finance.yahoo.com

What's your take on the Drug companies in general and are there any on this list you see as possible sell candidates.

Both Covidien plc (COV) and Becton, Dickinson and Company C(NYSE: BDX) have been discussed as undervalued medical devise companies. These too are trading at or near their 52wk highs.
finance.yahoo.com

At 16 PE these companies might be considered near a fair value level but their forward PE's are lower around 13. IMO these are still holds and to me continue to be undervalued.

In both the Drug stocks & Medical equipment companies we are having a stealth rally.

EKS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext